Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Pulmonary Hypertension, April 2025 Free Subscription Abstracts Retrieve all available abstracts of the following 154 articles: HTML format

Single Articles

1. GRYGIEL-GORNIAK B, Lucki M, Daroszewski P, Lucka E, et al
   Prevalence, molecular mechanisms and diagnostic approaches to pulmonary arterial hypertension in connective tissue diseases.
   Rheumatol Int. 2025;45:87.
   PubMed    
   Abstract available
   
   

2. ADELPARVAR F, Fakhrolmobasheri M, Qorbani F, Shafie D, et al
   Sodium-Glucose Cotransporter 2 Inhibitors and Pulmonary Hypertension: A Systematic Review.
   Cardiol Rev. 2025 Apr 4. doi: 10.1097/CRD.0000000000000888.
   PubMed    
   Abstract available
   
   

3. CASH M, Giambra B, Stone L, Magness M, et al
   Hank the Heart and Animation-Based Education for Pulmonary Hypertension.
   Pulm Circ. 2025;15:e70072.
   PubMed    
   Abstract available
   
   

4. KIRKPATRICK EC, Handler S, Liegl M, Pan AY, et al
   Pediatric Pulmonary Hypertension is Associated With Increased Circulating Levels of BMP 7 and CHIP.
   Pulm Circ. 2025;15:e70068.
   PubMed    
   Abstract available
   
   

5. LV G, Li A, Zhai Y, Li L, et al
   Assessment of right ventricle-to-pulmonary artery coupling by three-dimensional echocardiography in pre-capillary pulmonary hypertension: comparison with tricuspid annular plane systolic excursion /systolic pulmonary artery pressure ratio.
   BMC Med Imaging. 2025;25:108.
   PubMed    
   Abstract available
   
   

6. RATWATTE S, Stewart S, Playford D, Strange G, et al
   Characteristics of pulmonary hypertension in adults with left ventricular diastolic dysfunction.
   Open Heart. 2025;12:e003174.
   PubMed    
   Abstract available
   
   

7. LIMA LNG, Veronez V, Mendes PRA, Kiyota TA, et al
   Relationships that perceived barriers to physical activity have with functional capacity and quality of life in patients with pulmonary hypertension.
   J Bras Pneumol. 2025;51:e20240195.
   PubMed    
   Abstract available
   
   

8. ZHANG J, Zhang W, Yang Z, Fan B, et al
   Cinnamaldehyde alleviates pulmonary hypertension by affecting vascular remodeling through the TLR4/NF-kB/HIF-1a pathway.
   Clin Exp Hypertens. 2025;47:2486829.
   PubMed    
   Abstract available
   
   

9. ZHOU D, Wang T, Chen Y, Zheng Y, et al
   Characteristics and sex differences in bronchopulmonary dysplasia-related pulmonary hypertension.
   BMC Pulm Med. 2025;25:148.
   PubMed    
   Abstract available
   
   

10. GUO L, Ji K, Yin Y
    SIRT5 Inhibits Mitophagy and Inflammation of Hypoxia-Induced Pulmonary Hypertension by Regulating the Desuccinylation of PDK1.
    Mol Biotechnol. 2025 Apr 1. doi: 10.1007/s12033-025-01430.
    PubMed    
    Abstract available
    
    

11. YUAN X, Guo X, Luo Y, Guan X, et al
    PHNet: A pulmonary hypertension detection network based on cine cardiac magnetic resonance images using a hybrid strategy of adaptive triplet and binary cross-entropy losses.
    IEEE Trans Med Imaging. 2025;PP.
    PubMed    
    Abstract available
    
    

12. WANG L, Wang W, Wu T, Chen L, et al
    Mesenchymal Stem Cell-based Apelin Gene Therapy Improves Pulmonary Artery Remodeling in Monocrotaline-induced Pulmonary Hypertension Through PI3K/AKT/eNOS and ERK1/2 Signaling Pathways.
    J Cardiovasc Transl Res. 2025 Apr 1. doi: 10.1007/s12265-025-10612.
    PubMed    
    Abstract available
    
    

13. YOGESWARAN A, Petermann R, Kremer NC, Schafer S, et al
    Right ventricular-pulmonary arterial coupling predicts mortality in precapillary pulmonary hypertension.
    ERJ Open Res. 2025;11:00685-2024.
    PubMed    
    Abstract available
    
    

14. JEFFREYS E, Arattu Thodika FMS, Bell A, Greenough A, et al
    Mechanisms of hypoxaemia in late pulmonary hypertension associated with bronchopulmonary dysplasia.
    J Perinat Med. 2025 Apr 2. doi: 10.1515/jpm-2025-0058.
    PubMed    
    
    
    

15. OGURA Y, Imai E, Taito S, Tsuji T, et al
    Inhaled vs. Intravenous Vasodilators in Perioperative Pulmonary Hypertension during Chest Surgery Using Cardiopulmonary Bypass: A Systematic Review and Meta-analysis.
    Pulm Pharmacol Ther. 2025 Mar 29:102357. doi: 10.1016/j.pupt.2025.102357.
    PubMed    
    
    
    

16. NG IKS, Thong C, Singh GD, Daniel P, et al
    Diagnostic evaluation and management of pulmonary hypertension with concomitant incidental partial anomalous pulmonary venous return.
    Oxf Med Case Reports. 2025;2025:omae214.
    PubMed    
    Abstract available
    
    

17. BATOOL Z, Amjad Kamal M, Shen B
    Advanced treatment strategies for high-altitude pulmonary hypertension employing natural medicines: A review.
    J Pharm Anal. 2025;15:101129.
    PubMed    
    Abstract available
    
    

18. WANG Y, Wang Y, Zhang W
    Dysregulation of Mitochondrial in Pulmonary Hypertension-Related Right Ventricular Remodeling: Pathophysiological Features and Targeting Drugs.
    Rev Cardiovasc Med. 2025;26:25781.
    PubMed    
    Abstract available
    
    

19. MATUSOV G, Shams M, Ibrahim K, Hovsepyan A, et al
    Risk Factors for Adverse Outcomes in Connective Tissue Disease-Associated Pulmonary Hypertension.
    Rev Cardiovasc Med. 2025;26:26877.
    PubMed    
    Abstract available
    
    

20. SUN WL, Chen YH
    [Impact and management of comorbidities in patients with chronic obstructive pulmonary disease and obstructive sleep apnea].
    Zhonghua Jie He He Hu Xi Za Zhi. 2025;48:392-395.
    PubMed    
    Abstract available
    
    

21. LIU C, Meng F
    Identification of potential causal genes and drug targets in pulmonary hypertension based on transcriptomic analysis and Mendelian randomization.
    Postgrad Med J. 2025 Mar 29:qgaf044. doi: 10.1093.
    PubMed    
    Abstract available
    
    

22. LOPES JL, Ferreira F
    Pulmonary arterial aneurysm in a pulmonary hypertension patient.
    Rev Port Cardiol. 2025 Mar 26:S0870-2551(25)00095.
    PubMed    
    
    
    

23. PAEZ-CARPIO A, Gomez FM, Maschke S, Warren B, et al
    Cone Beam-CT pulmonary angiography in balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: A review of technical parameters and benefits.
    Eur J Radiol. 2025;186:112047.
    PubMed    
    Abstract available
    
    

24. KVITTING JP, Ravnestad H, Andersen R, Gjonnaess E, et al
    [Correction: Chronic thromboembolic pulmonary hypertension].
    Tidsskr Nor Laegeforen. 2025;145.
    PubMed    
    
    
    

25. LIANG J, Ba X, Wan L, Cui X, et al
    Risk factors and predictive model for pulmonary arterial hypertension in adult idiopathic-inflammatory-myopathy patients: A cross-sectional study.
    Clinics (Sao Paulo). 2025;80:100621.
    PubMed    
    Abstract available
    
    

26. ALTIN CELIK P, Aytekin M
    Extracellular matrix dynamics in a rat model of pulmonary arterial hypertension: unveiling the role of hyaluronan in disease pathology.
    J Hypertens. 2025 Jan 17. doi: 10.1097/HJH.0000000000003967.
    PubMed    
    Abstract available
    
    

27. PATA R, Kosuru B, Kristeva J
    Schistosomiasis-associated pulmonary arterial hypertension (Sch-PAH): A comprehensive review of diagnosis and management.
    Respir Med. 2025;240:108026.
    PubMed    
    Abstract available
    
    

28. SATO H, Nagano T, Suraya R, Hazama D, et al
    Reduction in circulating Endothelin-1 levels by inhaled COPD medications.
    Respir Med. 2025;240:108027.
    PubMed    
    Abstract available
    
    

29. ZHANG C, Ding H, Li J, Ramey DR, et al
    Epidemiology, disease burden of pulmonary arterial hypertension in China: A systematic literature review.
    Respir Med. 2025;240:108007.
    PubMed    
    Abstract available
    
    

30. RAHAGHI FF, Humbert M, Hoeper MM, White RJ, et al
    Future treatment paradigms in pulmonary arterial hypertension: a personal view from physicians, health authorities, and patients.
    Lancet Respir Med. 2025;13:364-370.
    PubMed    
    Abstract available
    
    

31. CACCIAPAGLIA F, De Angelis R, Ferri C, Bajocchi G, et al
    Pulmonary Arterial Hypertension Incidence in Patients With Systemic Sclerosis Treated With Bosentan for Digital Ulcers: Evidence From the SPRING-SIR Registry.
    J Rheumatol. 2025;52:375-382.
    PubMed    
    Abstract available
    
    

32. ALBANELL-FERNANDEZ M, Mestre MM, Lopez B, Gonzalez-Garcia R, et al
    Treatment patterns and factors associated with adherence in pulmonary arterial hypertension.
    Farm Hosp. 2025;49:T72-T78.
    PubMed    
    Abstract available
    
    

33. DAIGO K, Hiraide T, Momoi M, Shinya Y, et al
    Pulmonary arterial hypertension therapies in patients with obesity hypoventilation syndrome: a case series.
    J Clin Sleep Med. 2025;21:723-732.
    PubMed    
    Abstract available
    
    

34. FELLOWS AL, Chen CN, Xie C, Iyer N, et al
    ARF6 as a Novel Activator of HIF-2alpha in Pulmonary Arterial Hypertension.
    Am J Respir Cell Mol Biol. 2025;72:380-392.
    PubMed    
    Abstract available
    
    

35. BURGER CD, Saunders H, Hodge DO, Safford RE, et al
    Echocardiography Screening of Consecutive Patients With Portal Hypertension Referred to Mayo Clinic for Liver Transplant Evaluation.
    Mayo Clin Proc. 2025;100:668-679.
    PubMed    
    Abstract available
    
    

36. HARI GOPAL S, Tillman R, Hammond Ii JD, Hagan JL, et al
    Association between Time with Open Ductus Arteriosus and Outcomes in Congenital Diaphragmatic Hernia.
    Neonatology. 2024 Nov 6:1-8. doi: 10.1159/000541385.
    PubMed    
    Abstract available
    
    

37. YILDIZELI SO, Arikan H, Gungor S, Tufan A, et al
    Pulmonary Endarterectomy: Risk Factors for Early and Late Mortality.
    Thorac Cardiovasc Surg. 2025;73:230-236.
    PubMed    
    Abstract available
    
    

38. ALBANELL-FERNANDEZ M, Mestre MM, Lopez B, Gonzalez-Garcia R, et al
    Treatment patterns and factors associated with adherence in pulmonary arterial hypertension.
    Farm Hosp. 2025;49:72-78.
    PubMed    
    Abstract available
    
    

39. ICHIMURA K, Gross A, Mathew RO, Salman L, et al
    Cardiorenal Syndrome in Right Heart Failure Due to Pulmonary Arterial Hypertension-The Right Ventricle as a Therapeutic Target to Improve Renal Function.
    Cardiovasc Drugs Ther. 2025;39:373-384.
    PubMed    
    Abstract available
    
    

40. KAUR G, Ahuja A, Sen A, Singhal P, et al
    An extremely rare case of Rogers syndrome or thiamine responsive megaloblastic anemia.
    Indian J Pathol Microbiol. 2025;68:158-160.
    PubMed    
    Abstract available
    
    

41. WIEDENROTH CB, Steinhaus K, Rolf A, Breithecker A, et al
    Patient-Reported Long-Term Outcome of Balloon Pulmonary Angioplasty for Inoperable CTEPH.
    Thorac Cardiovasc Surg. 2025;73:237-243.
    PubMed    
    Abstract available
    
    

42. BARENCO-MARINS TS, Seara FAC, Ponte CG, Nascimento JHM, et al
    Pulmonary Circulation Under Pressure: Pathophysiological and Therapeutic Implications of BK Channel.
    Cardiovasc Drugs Ther. 2025;39:415-433.
    PubMed    
    Abstract available
    
    

43. MITSUYAMA Y, Goda A, Takeuchi K, Kikuchi H, et al
    Prevalence and Determinants of Depression and Anxiety in Patients With Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension.
    Circ Rep. 2025;7:285-292.
    PubMed    
    Abstract available
    
    

44. UEDA J, Tsuji A, Aoki T, Asano R, et al
    Phase 2 Study to Evaluate the Efficacy and Safety of Inhaled Nitric Oxide Therapy in Patients With Severe Right Heart Failure Associated With Pulmonary Hypertension?- Protocol for the PHiNO Study.
    Circ Rep. 2025;7:308-312.
    PubMed    
    Abstract available
    
    

45. LV W, Gu X, Zeng L, Liu K, et al
    Endothelial SMAD4 Deficiency Promotes Pulmonary Hypertension by Impairing Cell Adhesion and Extracellular Matrix Organization.
    Hypertension. 2025 Apr 11. doi: 10.1161/HYPERTENSIONAHA.124.22782.
    PubMed    
    Abstract available
    
    

46. CHEUNGPASITPORN W, Krisanapan P, Suppadungsuk S, Thongprayoon C, et al
    Research trends and performance of endothelin A receptor antagonist in kidney care: a bibliometric analysis.
    Ren Fail. 2025;47:2487212.
    PubMed    
    Abstract available
    
    

47. MAZUREK JA, Germack HD, Gauthier-Loiselle M, Satija A, et al
    Impact of treatment escalation on rehospitalization among patients with pulmonary arterial hypertension.
    Sci Rep. 2025;15:12235.
    PubMed    
    Abstract available
    
    

48. TOBITA K, Sakamoto H, Inami T, Fujisawa D, et al
    Preference for advance care planning in patients with pulmonary hypertension.
    Heart Vessels. 2025 Apr 10. doi: 10.1007/s00380-025-02542.
    PubMed    
    Abstract available
    
    

49. LI Y, Liu Y, Liang Z, Jia S, et al
    Plasma IL4 Levels Linked to Pulmonary Hypertension Severity and Outcome.
    Clin Exp Pharmacol Physiol. 2025;52:e70040.
    PubMed    
    Abstract available
    
    

50. CRNKOVIC S, Thekkekara Puthenparampil H, Mulch S, Biasin V, et al
    Adventitial fibroblasts direct smooth muscle cell-state transition in pulmonary vascular disease.
    Elife. 2025;13:RP98558.
    PubMed    
    Abstract available
    
    

51. KHOURY WEI, Chan SY
    When cell teamwork turns toxic.
    Elife. 2025;14:e106689.
    PubMed    
    Abstract available
    
    

52. WANG Z, Li N, Qiao N, Li L, et al
    ACVRL1 variation-induced hereditary hemorrhagic telangiectasia presenting with pulmonary arterial hypertension: clinical and genetic analyses of three case studies.
    BMC Cardiovasc Disord. 2025;25:271.
    PubMed    
    Abstract available
    
    

53. ZHAO W, Huang Z, Diao X, Yang Z, et al
    Development and validation of multimodal deep learning algorithms for detecting pulmonary hypertension.
    NPJ Digit Med. 2025;8:198.
    PubMed    
    Abstract available
    
    

54. WACKER J, Beghetti M
    Pulmonary hypertension in pediatrics: from clinical suspicion to management.
    Eur J Pediatr. 2025;184:288.
    PubMed    
    Abstract available
    
    

55. CODULLO V, Acquaro M, Greco A, Lia M, et al
    Right atrial reservoir strain as an early predictor of pulmonary hypertension development in Systemic Sclerosis: a single center pilot study.
    Rheumatology (Oxford). 2025 Apr 9:keae628. doi: 10.1093.
    PubMed    
    Abstract available
    
    

56. XIONG G
    Post-capillary pulmonary hypertension in heart failure: addressing statistical and methodological issues in research.
    Eur Heart J. 2025 Apr 8:ehae812. doi: 10.1093.
    PubMed    
    
    
    

57. FAUVEL C, Lamblin N
    Post-capillary Pulmonary Hypertension in Heart Failure is associated with higher mortality and morbidity risk: not just a matter of << hasard >>.
    Eur Heart J. 2025 Apr 8:ehae814. doi: 10.1093.
    PubMed    
    
    
    

58. NICCUM M, Avitabile CM, Albizem D, Meluskey H, et al
    Pulmonary Vascular Compromise is Associated with Survival in Pediatric Pulmonary Hypertension: A New Computational Model.
    medRxiv [Preprint]. 2025 Mar 26:2025.03.25.25324654.
    PubMed    
    Abstract available
    
    

59. KRISHNATHASAN K, Rafiq I, Dimopoulos K
    Editorial: Pulmonary hypertension in atrial septal defect.
    Front Cardiovasc Med. 2025;12:1589305.
    PubMed    
    
    
    

60. WANG Y, Sun L, Jia X, Yang M, et al
    miR-29 inhibits endothelial-to-mesenchymal transition in pulmonary hypertension of the newborn by regulating LRP6.
    FASEB J. 2025;39:e70502.
    PubMed    
    Abstract available
    
    

61. SALEY TP, Coleman RD
    Shedding Light on the Dark Side of the Moon-Understanding Pediatric Right Ventricular Work in Pulmonary Hypertension.
    Pulm Circ. 2025;15:e70070.
    PubMed    
    
    
    

62. LI SS, Guo M, Zhao Y, Fan F, et al
    Intranasal delivery of R8-modified circNFXL1 liposomes ameliorates Su5416-induced pulmonary arterial hypertension in C57BL/6 mice.
    Respir Res. 2025;26:127.
    PubMed    
    Abstract available
    
    

63. BREINIG S, Ehlinger V, Roze JC, Storme L, et al
    Neurodevelopmental outcomes at age 5 years among children born very preterm and surviving after persistent pulmonary hypertension of the newborn: EPIPAGE-2 cohort study.
    Eur J Paediatr Neurol. 2025;55:103-110.
    PubMed    
    Abstract available
    
    

64. WU Q, Li D, Ye H, Zhou Z, et al
    Cluster analysis reveals three clinical phenotypes of pulmonary artery hypertension associated with connective tissue diseases: insights into inflammation and immunity.
    Arthritis Res Ther. 2025;27:79.
    PubMed    
    Abstract available
    
    

65. DAI J, Ma L, Zhang Y, Shan L, et al
    The prognostic value of HFA-PEFF score in connective tissue disease-associated PAH: evidence from a cohort study.
    BMC Cardiovasc Disord. 2025;25:258.
    PubMed    
    Abstract available
    
    

66. REIMANN L, Preiss H, Muller J, Huber P, et al
    Medication adherence and clinical outcome in patients with pulmonary arterial hypertension or distal chronic thromboembolic pulmonary hypertension.
    BMJ Open Respir Res. 2025;12:e003023.
    PubMed    
    Abstract available
    
    

67. ZHOU X, Ren L, Meng X
    Considerations on patient age in the study of pulmonary hypertension and interstitial lung disease in Sjogren's syndrome.
    Int J Cardiol. 2025;431:133243.
    PubMed    
    
    
    

68. DAUNGSUPAWONG H, Wiwanitkit V
    Sjogren's syndrome and pulmonary hypertension: Correspondence.
    Int J Cardiol. 2025;431:133242.
    PubMed    
    
    
    

69. ZHANG RS, Jin L, Falco G, Axman R, et al
    Prognostic value of the right ventricular to left ventricular volume ratio on cardiac magnetic resonance imaging in predicting adverse outcomes for adults with pulmonary hypertension.
    Prog Cardiovasc Dis. 2025 Apr 2:S0033-0620(25)00046.
    PubMed    
    Abstract available
    
    

70. BENAVIDES-CORDOBA V, Palacios M, Vonk-Noordegraaf A
    Historical milestones and future horizons: exploring the diagnosis and treatment evolution of the pulmonary arterial hypertension in adults.
    Expert Opin Pharmacother. 2025;26:743-753.
    PubMed    
    Abstract available
    
    

71. ELBAZ MSM, Shafeghat M, Freed BH, Sarnari R, et al
    3D Vortex-Energetics in the Left Pulmonary Artery for Differentiating Pulmonary Arterial Hypertension and Pulmonary Venous Hypertension Groups Using 4D Flow MRI.
    J Magn Reson Imaging. 2024 Oct 28. doi: 10.1002/jmri.29635.
    PubMed    
    Abstract available
    
    

72. PALICI C, Florentin Vreju A, Bita CE, Dinescu SC, et al
    Capillaroscopic insights: exploring the connection between microvascular changes and pulmonary manifestations in systemic sclerosis.
    Rom J Intern Med. 2025;63:39-48.
    PubMed    
    Abstract available
    
    

73. CHEN B, Xia Y, Jiang Y, Sun Z, et al
    Non-Coding RNA Networks in Pulmonary Arterial Hypertension.
    Pharmacology. 2025;110:110-121.
    PubMed    
    Abstract available
    
    

74. GESANG L, Suona Y, Danzeng Z, Ci B, et al
    A machine learning-based severity stratification tool for high altitude pulmonary edema.
    BMC Med Inform Decis Mak. 2025;25:171.
    PubMed    
    Abstract available
    
    

75. REMY-JARDIN M, Duhamel A, Delobelle M, Bervar JF, et al
    Lung microvasculopathy in chronic thromboembolic pulmonary hypertension: high-resolution findings with photon-counting detector CT in 29 patients.
    Eur Radiol. 2025 Apr 18. doi: 10.1007/s00330-025-11561.
    PubMed    
    Abstract available
    
    

76. QIN Y, Zhang J, Wang A, Sun W, et al
    Multi-omics analysis of two rat models reveals potential role of vesicle transport and autophagy in right ventricular remodeling.
    Sci Rep. 2025;15:13401.
    PubMed    
    Abstract available
    
    

77. ERRINGTON N, Zhou L, Rhodes CJ, Fong YL, et al
    Diagnostic MicroRNA Signatures to Support Classification of Pulmonary Hypertension.
    Circ Genom Precis Med. 2025 Apr 18:e004862. doi: 10.1161/CIRCGEN.124.004862.
    PubMed    
    Abstract available
    
    

78. GRIMBERGEN E, van Aarssen SPM, Staal DP, Peper J, et al
    Diagnostic Accuracy of the Malnutrition Universal Screening Tool and Mini Nutritional Assessment Short-Form in Outpatients With Pulmonary Hypertension.
    Pulm Circ. 2025;15:e70075.
    PubMed    
    Abstract available
    
    

79. COPPI F, Pagnoni G, Campani C, Grossule F, et al
    Reply to "Considerations on Patient Age in the Study of Pulmonary Hypertension and Interstitial Lung Disease in Sjogren's Syndrome".
    Int J Cardiol. 2025 Apr 15:133285. doi: 10.1016/j.ijcard.2025.133285.
    PubMed    
    
    
    

80. COPPI F, Pagnoni G, Campani C, Grossule F, et al
    Reply to " Sjogren's syndrome and pulmonary hypertension: Correspondence".
    Int J Cardiol. 2025 Apr 15:133286. doi: 10.1016/j.ijcard.2025.133286.
    PubMed    
    
    
    

81. EL KHOURY W, Chan SY
    TBX4 in Pulmonary Hypertension: Linking Lung Development to Precision Therapy.
    Am J Respir Cell Mol Biol. 2025 Apr 17. doi: 10.1165/rcmb.2025-0164.
    PubMed    
    
    
    

82. HONDA S, Yamano M, Kawasaki T
    Systolic Ejection Murmur in a Case of Patent Ductus Arteriosus and Pulmonary Hypertension With Liver Cirrhosis.
    Cureus. 2025;17:e80691.
    PubMed    
    Abstract available
    
    

83. HAO SY, Muhetaer Y, Zheng X, Long YL, et al
    Rapid improvement in postpartum pulmonary hypertension associated with hereditary hemorrhagic telangiectasia: A case report and review of literature.
    World J Clin Cases. 2025;13:98128.
    PubMed    
    Abstract available
    
    

84. PAN J, Wu Q, Chen S, Wang H, et al
    Clinical outcomes of pregnancy in patients with pulmonary hypertension: A single center observational study.
    J Cardiothorac Surg. 2025;20:199.
    PubMed    
    Abstract available
    
    

85. ZHANG J, Song Y, Wang X, Wang X, et al
    The transcription factor PITX1 cooperates with super-enhancers to regulate the expression of DUSP4 and inhibit pyroptosis in pulmonary artery smooth muscle cells.
    Respir Res. 2025;26:149.
    PubMed    
    Abstract available
    
    

86. KIKO T, Asano R, Ishibashi T, Endo H, et al
    Balloon Pulmonary Angioplasty in Heterozygous RNF213 p.Arg4810Lys Variant Carriers Diagnosed With Chronic Thromboembolic Pulmonary Hypertension.
    J Am Heart Assoc. 2025 Apr 16:e039002. doi: 10.1161/JAHA.124.039002.
    PubMed    
    Abstract available
    
    

87. WU SH, Wu YJ
    Precision Medicine in Chronic Thromboembolic Pulmonary Hypertension: Unraveling the Genetic Impact of RNF213 p.Arg4810Lys on Balloon Pulmonary Angioplasty Outcomes.
    J Am Heart Assoc. 2025 Apr 16:e041544. doi: 10.1161/JAHA.125.041544.
    PubMed    
    
    
    

88. SRIDHAR M, Tauquir A, Sahay S, Tonelli AR, et al
    Frailty in Pulmonary Hypertension: A Multidimensional Comorbidity.
    Ann Am Thorac Soc. 2025 Apr 16. doi: 10.1513/AnnalsATS.202410-1009.
    PubMed    
    Abstract available
    
    

89. ZHAO Z, He X, Xiong R, Cui Y, et al
    Association of echocardiographic pulmonary hypertension with all-cause mortality in hospitalized AECOPD patients.
    Int J Cardiol Heart Vasc. 2025;58:101661.
    PubMed    
    Abstract available
    
    

90. HARPER RL, Zhou X, Marciano DP, Cao A, et al
    Altered maturation and activation state of circulating monocytes is associated with their enhanced recruitment in pulmonary arterial hypertension.
    Respir Res. 2025;26:148.
    PubMed    
    Abstract available
    
    

91. ZHANG Y, Song HX, Qi YJ, Sun NN, et al
    Ultrasound-guided transbronchial biopsy in the diagnosis of fibrosing mediastinitis-associated pulmonary hypertension.
    Orphanet J Rare Dis. 2025;20:180.
    PubMed    
    Abstract available
    
    

92. LIU Z, Bai Z, Chen X, Chen Y, et al
    Advances and applications of biosensors in pulmonary hypertension.
    Respir Res. 2025;26:147.
    PubMed    
    Abstract available
    
    

93. CONDE-CAMACHO R, Tuta-Quintero E, Bastidas-Goyes A, Giraldo-Cadavid LF, et al
    Survival rates at one and five years for patients with group 1 pulmonary arterial hypertension at high altitude: A retrospective cohort study.
    Sci Prog. 2025;108:368504251336066.
    PubMed    
    Abstract available
    
    

94. ABDELMASSIH AF, ElAnwary S, Taha N, Radwan N, et al
    Circulating Intercellular Adhesion Molecule as a Novel Marker of Pulmonary Hypertension in Newborn.
    Indian Pediatr. 2025 Apr 15. doi: 10.1007/s13312-025-00037.
    PubMed    
    Abstract available
    
    

95. NAVARRO-GARCIA JA, Osborne AJ, Wehrens XHT
    MicroRNA-210-5p - a New Druggable Target for Pulmonary Hypertension?
    Cardiovasc Drugs Ther. 2025 Apr 15. doi: 10.1007/s10557-025-07701.
    PubMed    
    
    
    

96. DIAZ GF, Diaz-Castrillon CE, Marquez Garcia A, Hopper RK, et al
    Importance of age at diagnosis of pulmonary hypertension in children living at high altitude: Longitudinal follow-up of 86 patients.
    Pulm Circ. 2025;15:e70017.
    PubMed    
    Abstract available
    
    

97. OKHRIMENKO G, Borovikova I, Dankovtseva E, Zamyatin V, et al
    The prevalence of pathogenic variants in the BMPR2 gene in patients with the idiopathic pulmonary arterial hypertension in the Russian population: sequencing data and meta-analysis.
    Respir Res. 2025;26:146.
    PubMed    
    Abstract available
    
    

98. KURONUMA K, Shimokawahara H, Matsubara H
    An overview of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.
    Expert Rev Respir Med. 2025 Apr 14. doi: 10.1080/17476348.2025.2491721.
    PubMed    
    Abstract available
    
    

99. KOGA Y, Tahara N, Fukumoto Y
    Balloon pulmonary angioplasty with inotropic agent and pulmonary vasodilators for chronic thromboembolic pulmonary hypertension.
    Eur Heart J Case Rep. 2025;9:ytaf153.
    PubMed    
    
    
    

100. LIU Y, Wang R, Jiang T
     RNA-binding proteins as a molecular link between COPD and pulmonary hypertension.
     Int J Med Sci. 2025;22:1979-1991.
     PubMed    
     Abstract available
     
     

101. BERRAJAA M, Babakhouya A, El Minaoui M
     Right cardiac failure and pulmonary hypertension secondary to tonsil hypertrophy in a 3-year-old boy: a case report.
     Pan Afr Med J. 2025;50:2.
     PubMed    
     Abstract available
     
     

102. EL SHAER A, Garcia-Arango M, Abed A, Heffernan S, et al
     Breaking down the recovery of O(2) pathway: Peripheral extraction recovery pattern defines exercise capacity and clinical outcomes.
     Physiol Rep. 2025;13:e70337.
     PubMed    
     Abstract available
     
     

103. RODRIGUEZ-CHIARADIA DA, Torres-Castro R, Piccari L, Garcia-Ortega A, et al
     A Systematic Review and Expert Recommendation on the Diagnosis of Pulmonary Hypertension Associated With Lung Disease: A Position Paper of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR).
     Arch Bronconeumol. 2025 Mar 28:S0300-2896(25)00112.
     PubMed    
     Abstract available
     
     

104. LUZ JM, Ferreira F, Alegria S, Vieira AC, et al
     Can my echo work as a crystal ball? - Echocardiographic parameters predicting residual pulmonary hypertension after pulmonary endarterectomy.
     Rev Port Cardiol. 2025 Apr 11:S0870-2551(25)00119.
     PubMed    
     Abstract available
     
     

105. XU J, Wang Y, Gong Y, Wang L, et al
     A nomogram model based on clinical and 3D-EIT parameters for CTEPH diagnosis.
     Respir Res. 2025;26:137.
     PubMed    
     Abstract available
     
     

106. SHI J, Liang J, Wang J, Wang H, et al
     Assessment of biomechanical properties in pulmonary arterial hypertension: a computational fluid dynamics study of the extensive pulmonary arterial tree.
     BMC Pulm Med. 2025;25:175.
     PubMed    
     Abstract available
     
     

107. LEITE LB, Soares LL, Guimaraes-Ervilha LO, Costa SFF, et al
     Blueberry Extract and Resistance Training Prevent Left Ventricular Redox Dysregulation and Pathological Remodeling in Experimental Severe Pulmonary Arterial Hypertension.
     Nutrients. 2025;17:1145.
     PubMed    
     Abstract available
     
     

108. SHANCUOJI, Liao Y, Li J, Chen M, et al
     The Prognostic Value of Pulmonary Hypertension in Patients with Mitral Regurgitation Undergoing Mitral Valve Transcatheter Edge-to-Edge Repair: A Systematic Review and Meta-Analysis.
     Diagnostics (Basel). 2025;15:852.
     PubMed    
     Abstract available
     
     

109. OLIVEROS E, Jonnalagadda A, Vaidya A
     Pulmonary Hypertension: Updates in Diagnosis and Management.
     J Clin Med. 2025;14:2400.
     PubMed    
     Abstract available
     
     

110. DOU LZ, Li SS, Wang S, Jiang H, et al
     Prognostic value of non-invasive right ventricle-pulmonary artery coupling in patients with pulmonary hypertension associated with left heart disease.
     J Cardiothorac Surg. 2025;20:185.
     PubMed    
     Abstract available
     
     

111. JIN Y, Mao F, Wang X, Zhang J, et al
     The sonic hedgehog signaling inhibitor cyclopamine improves pulmonary arterial hypertension via regulating the bone morphogenetic protein receptor 2 pathway.
     Sci Rep. 2025;15:12512.
     PubMed    
     Abstract available
     
     

112. CHANG TC, Wang CM, Ho CH, Chen YC, et al
     A prevalence study focusing on hospitalized COPD related pulmonary hypertension.
     Sci Rep. 2025;15:12426.
     PubMed    
     Abstract available
     
     

113. MENG Y, Zheng C, Zhang X, Gao Z, et al
     xCT/Slc7a11 promotes pulmonary arterial hypertension by disrupting AMPKalpha suppression of mTOR activation.
     Biochem Pharmacol. 2025;236:116897.
     PubMed    
     Abstract available
     
     

114. HUANG H, Xue H, Cai A, Yuan H, et al
     Discovery of novel azetidine-based imidazopyridines as selective and orally bioavailable inhibitors of phosphodiesterase 10A for the treatment of pulmonary arterial hypertension.
     Eur J Med Chem. 2025;290:117537.
     PubMed    
     Abstract available
     
     

115. FAN F, Davis S, Burbridge C, Chin K, et al
     Single-Tablet Combination Therapy of Macitentan/Tadalafil for Patients with Pulmonary Arterial Hypertension: Qualitative Interview Study of the A DUE Phase 3 Trial.
     Adv Ther. 2025;42:2298-2313.
     PubMed    
     Abstract available
     
     

116. ZHOU JJ, Jing-Li, Luo CL, He YH, et al
     NEK2 inhibition reverses vascular remodeling in pulmonary arterial hypertension associated with congenital heart disease.
     Cell Signal. 2025;131:111720.
     PubMed    
     Abstract available
     
     

117. NABATY NL, Tobin JA
     Utility of acetazolamide for headaches in the setting of pulmonary arterial hypertension - A case report.
     Headache. 2025;65:892-896.
     PubMed    
     Abstract available
     
     

118. AKIN MS, Kas G, Aydin E, Cetinkaya AK, et al
     Association between early pulmonary arterial pressure measurements and bronchopulmonary dysplasia or mortality in very preterm infants: a prospective cohort study.
     Arch Dis Child Fetal Neonatal Ed. 2025;110:291-296.
     PubMed    
     Abstract available
     
     

119. HINDMARCH CCT, Potus F, Al-Qazazi R, Ott BP, et al
     Tet Methylcytosine Dioxygenase 2 (TET2) Mutation Drives a Global Hypermethylation Signature in Patients With Pulmonary Arterial Hypertension (PAH): Correlation With Altered Gene Expression Relevant to a Common T Cell Phenotype.
     Compr Physiol. 2025;15:e70011.
     PubMed    
     Abstract available
     
     

120. MURTA MS, Duarte RLM, Waetge D, Gozal D, et al
     Exercise-induced oxyhemoglobin desaturation is an independent risk factor for sustained nocturnal hypoxemia in adults with precapillary pulmonary hypertension: A cross-sectional study.
     Heart Lung. 2025;73:26-32.
     PubMed    
     Abstract available
     
     

121. CHEN J, Jiang C, Hu X, Zhang Y, et al
     Mechanism of pulmonary arterial vascular cell dysfunction in pulmonary hypertension in broiler chickens.
     Avian Pathol. 2025 Apr 24:1-12. doi: 10.1080/03079457.2025.2480802.
     PubMed    
     Abstract available
     
     

122. MATSUO S, Ozaki K, Kashimura T, Matsuo Y, et al
     Left main compression syndrome caused by pulmonary hypertension due to peripheral pulmonary artery stenosis complicated with moyamoya disease.
     J Cardiol Cases. 2025;31:29-34.
     PubMed    
     Abstract available
     
     

123. MIRANI B, Dauz JD, Yazaki K, Latifi N, et al
     Right Ventricular Stiffening and Function Are Associated With Main Pulmonary Artery Remodeling in a Rat Model of Pulmonary Hypertension.
     Arterioscler Thromb Vasc Biol. 2025 Apr 24. doi: 10.1161/ATVBAHA.124.321354.
     PubMed    
     Abstract available
     
     

124. AOKI T, Miyamoto T, Kizaki K, Ueshima A, et al
     Ante-mortem diagnosis of unilateral pulmonary vein stenosis in a cat: a case report.
     Acta Vet Scand. 2025;67:21.
     PubMed    
     Abstract available
     
     

125. HATIPOGLU US, Smith M, Arrossi AV, Tonelli AR, et al
     Pulmonary veno-occlusive disease: atypical presentation with unexplained exertional dyspnoea and hypoxaemia.
     BMJ Case Rep. 2025;18:e265170.
     PubMed    
     Abstract available
     
     

126. HU XQ, Song R, Dasgupta C, Twum-Barimah S, et al
     MicroRNA-210 Mediates Hypoxic Pulmonary Hypertension in the Newborn Lamb.
     Hypertension. 2025 Apr 23. doi: 10.1161/HYPERTENSIONAHA.124.23061.
     PubMed    
     Abstract available
     
     

127. CHRISTOPHER MALAISRIE S, Chiu S, Schimmel D, Samant M, et al
     Outcomes of Multidisciplinary Care at a Chronic Thromboembolic Pulmonary Hypertension Center.
     Pulm Circ. 2025;15:e70085.
     PubMed    
     Abstract available
     
     

128. SHIDA Y, Takahashi T, Aoyama R, Seki S, et al
     Dasatinib-induced pulmonary hypertension presenting with hoarseness: Ortner's syndrome.
     BMJ Case Rep. 2025;18:e263874.
     PubMed    
     
     
     

129. YOSHIDA T, Adin D, Matsuura K
     Clinical Outcomes of Mitral Valve Repair in Dogs With Pulmonary Hypertension Secondary to Myxomatous Mitral Valve Disease.
     J Vet Intern Med. 2025;39:e70106.
     PubMed    
     Abstract available
     
     

130. ALMUBAREK M, Louw EH, Griffith-Richards S, Ackermann C, et al
     Computed tomography chest imaging for the detection of pulmonary hypertension in patients with post-tuberculosis lung disease.
     Afr J Thorac Crit Care Med. 2025;31:e1948.
     PubMed    
     Abstract available
     
     

131. SATO J, Hino H, Watanabe R, Mori T, et al
     Severe pulmonary hypertension in weaning from cardiopulmonary bypass following double Ozaki procedure: a case report.
     JA Clin Rep. 2025;11:23.
     PubMed    
     Abstract available
     
     

132. WANG H, Peng LJ, Lu W, Li GR, et al
     Acacetin reverses hypoxic pulmonary hypertension by inhibiting hypoxia-induced proliferation of pulmonary artery smooth muscle cells via SIRT1-HMGB1 pathway.
     Eur J Pharmacol. 2025 Apr 19:177650. doi: 10.1016/j.ejphar.2025.177650.
     PubMed    
     Abstract available
     
     

133. SUOLITIKEN D, Han X, Feng C, Wang Y, et al
     Transformed to myelofibrosis is a risk factor for pulmonary hypertension in Philadelphia chromosome-negative myeloproliferative neoplasms.
     Ann Hematol. 2025 Apr 21. doi: 10.1007/s00277-025-06334.
     PubMed    
     Abstract available
     
     

134. GHEYTASPOUR P, Bahadoran S, Hassanpour H
     The Impact of Dietary Melatonin on Heart and Lung Telomere Length and Shelterin Protein Gene Expression of Pulmonary Hypertensive Broiler Chickens.
     Vet Med Sci. 2025;11:e70355.
     PubMed    
     Abstract available
     
     

135. ABDALLAH N, Alsayed M
     Pulmonary hypertension and outcomes following left atrial appendage occlusion device placement for atrial fibrillation: A population-based analysis.
     J Arrhythm. 2025;41:e70071.
     PubMed    
     Abstract available
     
     

136. KING MH, Li C, Bond VC, Ford D, et al
     Prevalence and Economic Burden of Pulmonary Hypertension and Pulmonary Arterial Hypertension Among the Medicaid Population.
     Pulm Circ. 2025;15:e70060.
     PubMed    
     Abstract available
     
     

137. STRICK DJ, Tanba C, Kaplan MA, Hill NS, et al
     A Prospective Analysis of Vasoreactivity and Mortality in WHO Group 3 Pulmonary Hypertension.
     Pulm Circ. 2025;15:e70078.
     PubMed    
     Abstract available
     
     

138. DASGUPTA S
     Drug Design in the Age of Network Medicine and Systems Biology: Transcriptomics Identifies Potential Drug Targets Shared by Sarcoidosis and Pulmonary Hypertension.
     OMICS. 2025 Apr 21. doi: 10.1089/omi.2025.0031.
     PubMed    
     Abstract available
     
     

139. SOMA S, Yaoita N, Satoh T, Nochioka K, et al
     The difference of gas exchange pulmonary arterial capacitance with postural change between chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension.
     J Cardiol. 2025 Apr 17:S0914-5087(25)00102-9. doi: 10.1016/j.jjcc.2025.
     PubMed    
     Abstract available
     
     

140. GOOSSEN CJ, Kufner A, Dustin CM, Al Ghouleh I, et al
     Redox regulation of lung endothelial PERK, unfolded protein response (UPR) and proliferation via NOX1: Targeted inhibition as a potential therapy for PAH.
     Redox Biol. 2025;82:103554.
     PubMed    
     Abstract available
     
     

141. PAGNESI M, Riccardi M, Savonitto G, Ameri P, et al
     Sex differences in pulmonary arterial hypertension: Insights from the FOCUS-PAH registry.
     Int J Cardiol. 2025;430:133180.
     PubMed    
     Abstract available
     
     

142. LI W, Shang W, Huang J
     Pulmonary artery systolic pressure associated with inflammatory factors among pediatric congenital heart disease with pulmonary arterial hypertension after cardiopulmonary bypass.
     J Pediatr (Rio J). 2025;101:438-444.
     PubMed    
     Abstract available
     
     

143. MUNNEKE AG, Lumens J, Delhaas T
     Diagnostic value of reversed differential cyanosis in (supra)cardiac total anomalous pulmonary venous return.
     Pediatr Res. 2025;97:809-817.
     PubMed    
     Abstract available
     
     

144. SINGH N, Oldham WM
     Targeting Type-2 Inflammation in Pulmonary Hypertension: Lessons from a Novel Model.
     Am J Physiol Lung Cell Mol Physiol. 2025 Apr 7. doi: 10.1152/ajplung.00109.2025.
     PubMed    
     
     
     

145. LEARY PJ, Le RJ, Panjabi S, Hartney J, et al
     Location of Care Delivery for Pulmonary Arterial Hypertension in the United States.
     Am J Respir Crit Care Med. 2025;211:619-627.
     PubMed    
     Abstract available
     
     

146. KUDELKO K, Sung YK, Ventetuolo CE, Kawut S, et al
     National Consortium on Pulmonary Vascular Disease Fellowship Training Summary.
     Chest. 2025;167:1191-1203.
     PubMed    
     Abstract available
     
     

147. WALIGORA M, Kurzyna M, Mularek-Kubzdela T, Skoczylas I, et al
     Effects of beta-Blockers on the Outcomes in Patients With Pulmonary Arterial Hypertension Stratified by the Presence of Comorbid Conditions: A Multicenter Prospective Cohort Study: The Database of Pulmonary Hypertension in the Polish Population (BNP-P
     Chest. 2025;167:1171-1181.
     PubMed    
     Abstract available
     
     

148. MOUNSEY LA, Kalaria CJ, Kowal A, Hoenstine C, et al
     Exercise hemodynamics and the evolving definition of precapillary pulmonary hypertension.
     Chest. 2025 Apr 21:S0012-3692(25)00450-7. doi: 10.1016/j.chest.2025.
     PubMed    
     
     
     

149. KNOEPP F, Abid S, Houssaini A, Lipskaia L, et al
     Piezo1 in PASMCs: Critical for Hypoxia-Induced Pulmonary Hypertension Development.
     Circ Res. 2025 Apr 4. doi: 10.1161/CIRCRESAHA.124.325475.
     PubMed    
     Abstract available
     
     

150. LEMAY SE, Montesinos MS, Grobs Y, Yokokawa T, et al
     Exploring Integrin alpha5beta1 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension: Insights From Comprehensive Multicenter Preclinical Studies.
     Circulation. 2025 Jan 20. doi: 10.1161/CIRCULATIONAHA.124.070693.
     PubMed    
     Abstract available
     
     

151. BRAKSATOR M, Kurzyna M, Kopec G, Pruszczyk P, et al
     Hemodynamic, echocardiographic, and demographic profiles of patients with chronic thromboembolic pulmonary hypertension and atrial fibrillation: A multicenter cohort study.
     J Heart Lung Transplant. 2025 Apr 1:S1053-2498(25)01858.
     PubMed    
     Abstract available
     
     

152. REDDY SA, Pepke-Zaba J
     Evaluating the Influence of Atrial Fibrillation in Chronic Thromboembolic Pulmonary Hypertension.
     J Heart Lung Transplant. 2025 Apr 11:S1053-2498(25)01909.
     PubMed    
     
     
     

153. MULLALY R, Smith A, Murphy C, Armstrong S, et al
     Characteristics and outcomes of preterm infants with early pulmonary hypertension.
     J Perinatol. 2025 Apr 11. doi: 10.1038/s41372-025-02295.
     PubMed    
     Abstract available
     
     

154. VIJAYAKUMAR S, Louis DW, Corneau E, Erqou S, et al
     Association between pre-existing Pulmonary Hypertension and COVID-19 related outcomes in inpatient and ambulatory care settings.
     PLoS One. 2025;20:e0321964.
     PubMed    
     Abstract available